2022 NICER Symposium
A 3-day virtual symposium being held September 28-30, 2022 via Zoom
Mary C. Dinauer, MD PhD
Washington University in St. Louis
Speaking Thursday 9:10a-9:55a
Steven Holland, MD
Speaking Thursday 9:55a-10:40a
Ivona Aksentijevich, MD
Speaking Friday 9:10a-9:55a
Message from the 2022 NICER Virtual Symposium Directors
Welcome to the 2022 NICER Virtual Symposium, “The Lion, the Witch and the Wardrobe: Neutrophils, Macrophages and the Inflammasome – Stepping into Innate Immunity.” We are excited to have you join us as we venture through the closet doors into the riveting world of the innate immune system and challenge our expectations of phagocytes and inflammatory signaling cascades.
Like past years, the 2022 symposium will be host to fan favorites such as the “Pro-Con Debates” and “Tales of the Case Conference” where we will emphasize the multi-specialty nature of immuno-heme disorders and highlight recent advances along with ongoing knowledge gaps. There will also be mentoring and career development opportunities through “Speed Networking” and “Peer Mentoring,” which we hope you will thoroughly enjoy. Additionally, we are introducing new sessions focusing on giving back to both our academic peers and the patient communities on Wednesday through a morning primary-care oriented Immuno-Hematology 101 style course followed by a patient-directed afternoon co- hosted by Race for Immunology featuring a panel discussion on “Rare Disease: Breaking through Communication Barriers” alongside break out sessions on oral health, understanding genetic testing and navigating the transition from pediatric to adult care.
Looking forward to seeing you at the symposium!
Melissa Rose, DO Kelly Walkovich, MD
Symposium Planning Committee
Melissa Rose, DO
Irina Pateva, MD
UH Rainbow Babies & Children's
Kelly Walkovich, MD
University of Michigan
Steven Allen, MD
Ram Kalpatthi, MD
Race For Immunology
Hey Chong, MD PhD
Jackie Madison, MD
University of Michigan
Symposium Break Down
Continuing Medical Education Information
The 2022 NICER symposium offers a venue for multi-specialty discussion of immuno-hematologic disorders with a focus this year on disorders of innate immunity. Participates will have the opportunity to participate in interactive sessions directed at primary care recognition and management of immuno-heme disorders, learn about emerging phenotypes and new management strategies for innate disorders from national experts and participate in active patient case reviews, topic debates as well as learn new skills for career development in rare disease.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Michigan Medical School and North American Immuno-Hematology Clinical Education and Research Consortium. The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience: Physicians
1. Identify patients with infectious or inflammation symptoms at risk for underlying inborn errors of immunity and prioritize them for further immune evaluation.
2. Describe the role of neutrophils in the innate immune and inflammatory responses.
3. Discuss current limitations in diagnostic approaches and management strategies in macrophage and inflammasome driven disorders.
4. Illustrate the benefits of a multi-specialty approach to the care of patients with disorders of the innate immune system.
Clinical immunologists will apply triaging skills to recognize emerging phenotypes and innate immune disorders. Additionally, clinical immunologists will utilize knowledge learned to determine biologically rational management strategies. Primary care providers will practice identifying warning signs of an underlying immune disorder and how to provide initial management of immune disorders.
For more information visit: Michigan Medicine (highmarksce.com)